US FDA pledges to work with drug makers on shortages
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration has said it is willing to work with drug makers to do what it takes to prevent medicines shortages or quickly resolve an issue, expediting its regulatory processes, if needed, to fix a problem.